Impact of Viral Infections on Influenza Epidemiology

by

Influenza is often identified as the flu, thereby constituting a viral infection with severe public health impacts around the world. The epidemiology of influenza is quite complex and is impacted by many factors, such as the presence of other viruses. Co-circulating viruses may impact the dynamics of transmission and influenza outcomes. Understanding this relationship is key to enhancing prevention and control measures for flu outbreaks. In that respect, the reminder of this review will be how other past and present viral infections add to the epidemiology of influenza, learning from some of the most recent research and major findings and their implications.

Viral interference and the Dynamics of Infection

Viral interference is a process occurring in a host in which an infection with a virus suppresses the reproduction or transmission of another pathogen. This would occur by way of multiple mechanisms, including the host immune response having been activated against the first virus, hence making it much more difficult for the second virus to cause infection. For instance, respiratory viruses tend to interfere with influenza viruses. In fact, virus infections have been linked to the activity of influenza, most likely due to a competitive relationship between the two viruses.

By contrast, co-infections, in which an individual is infected with two or more viruses at the same time, can complicate the natural history of diseases. Co-infections of influenza with another respiratory virus, such as RSV or adenovirus, can result in a more severe clinical course and higher rates of hospitalization. The presence of more than one pathogen may actually serve to strengthen the immune response in the host, ultimately increasing inflammation and tissue damage.

Seasonality and Virus Interference

Seasonal patterns of viral infections may primarily drive influenza epidemiology. The peak for influenza typically presents variably during the winter in temperate regions. However, this is modified by interactions with other seasonal viruses. For instance, it was recently demonstrated that in seasons with high activity of non-influenza respiratory viruses, such as RSV and human metapneumovirus, anomalies in influenza transmission could occur. Such interactions change the timing, duration, and intensity of influenza outbreaks.

In the tropics, these interactions are likely to be even more complicated due to the potential for infections to be caused by circulating viruses all year round. The circulation of multiple related respiratory viruses at any point in time generates a dynamical process in which viral interference and co-infections are constantly modulating the epidemiology of influenza. Uncovering these patterns should help in the prediction and control of influenza outbreaks in contrasting climatic settings.

Yearwise Publication Trend on “viral infections”

Find publication trends on relevant topics

Immune responses and cross-protection

The immune response to viral infection may be a critical determinant of the epidemiology of influenza. The induction of an immune response by a viral infection may induce temporary cross-protection against other viruses, including influenza. The main manner in which this occurs is through the induction of large amounts of interferon and other cytokines that enhance the antiviral state in cells. The period and strength of that protection, however, could vary based on the viruses in question and a person’s immune status.

Studies have shown that primary infection with some respiratory viruses could reduce the number of subsequent influenza virus infections. For example, in young children, a recent RSV infection has been shown to be a protective factor associated with reduced severe influenza illnesses, most likely due to the immune response in the host being primed. Cross-protection of this sort can affect the epidemiology of the disease via a reduction in the number of serious cases and changes in the transmission dynamics.

The most important vaccination for controlling influenza is vaccination. Other viral infections, however, exist that may interact with the vaccines, hence the success in controlling public health. Co-circulating viruses influence the immunogenicity of influenza vaccines, which may result in decreased vaccine efficacy. For example, a recent infection by another respiratory virus may alter the host immune response to the influenza vaccine and reduce its protective efficiency.

Social distancing, hand hygiene, and wearing masks would interrupt most of the transmission of respiratory viruses other than the influenza virus. Massive implementation during the COVID-19 pandemic led to a remarkable fall in the circulation of influenza and other respiratory viruses, which only shows this viral interaction.

Recent Publications on “viral infections”

Find publications on relevant topics

Case reports and epidemiological evidence

There are a number of studies that have brought to light the epidemiological effect of viral infections on influenza. A multitude of studies that have been carried out on schoolchildren have reported that the circulation of various respiratory viruses can lead to varying transmissions of influenza among the children. It has been shown that circulation of influenza along with rhinovirus can result in a low incidence of the influenza virus, thus indicating viral interference.

Another research study involved patients hospitalized for severe acute respiratory infections, which showed that co-infections by influenza and other respiratory viruses were common and had worse clinical outcomes than others. These findings underpin the importance of considering the broader viral ecosystem when estimating influenza epidemiology and planning public health interventions.

Implications for Public Health and Future Research

Understanding these interactions between influenza and viral co-infections will be of crucial importance for public health. Surveillance systems for different respiratory viruses will be necessary to integrate into a single viral landscape. Such information would better inform the forecast of influenza and better predict the allocation of health care resources during its outbreaks.

Future studies should be directed toward mechanisms of viral interference and processes of infection; hence, how these diverse interactions affect vaccine effectiveness should be looked into. Another important research avenue is the role of host factors acting upon such viral interactions, including immune status and genetic susceptibility. The role of climate and other environmental factors in this interplay of respiratory viruses will be highly relevant for planning from a public health perspective.

Conclusion

The interrelation viral infections have in influenza epidemiology poses a really complex, multifaceted problem. Possible factors regulating influenza outbreak dynamics may involve interplays such as interference between viruses, co-infections, seasonal patterns of circulation, and host immune responses. Understanding these will help to improve prevention and control strategies for influenza, thereby reducing the enormous burden of this public health menace. Well-timed research and the merging of these approaches into public health management will be crucial toward combating the ever-evolving respiratory viral landscape.

References

  1. Guo G, Ye L, Pan K, Chen Y, Xing D, Yan K, Chen Z, Ding N, Li W, Huang H, Zhang L, Li X, Xue X. New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention. Front Cell Dev Biol. 2020 May 22;8:410. doi: 10.3389/fcell.2020.00410. PMID: 32574318; PMCID: PMC7256189.
  2. Zhao Y, Cui C, Zhang K, Liu J, Xu J, Nisenbaum E, Huang Y, Qin G, Chen B, Hoffer M, Blanton SH, Telischi F, Hare JM, Daunert S, Shukla B, Pahwa SG, Jayaweera DT, Farmer PE, Del Rio C, Liu X, Shu Y. COVID19: A Systematic Approach to Early Identification and Healthcare Worker Protection. Front Public Health. 2020 May 19;8:205. doi: 10.3389/fpubh.2020.00205. PMID: 32574296; PMCID: PMC7248242.
  3. Ali S, Noreen S, Farooq I, Bugshan A, Vohra F. Risk Assessment of Healthcare Workers at the Frontline against COVID-19. Pak J Med Sci. 2020 May;36(COVID19-S4):S99-S103. doi: 10.12669/pjms.36.COVID19-S4.2790. PMID: 32582323; PMCID: PMC7306961.
  4. Shi Q, Zhou Q, Wang X, Liao J, Yu Y, Wang Z, Lu S, Ma Y, Xun Y, Luo X, Li W, Fukuoka T, Ahn HS, Lee MS, Luo Z, Liu E, Chen Y, Li Q, Yang K, Guan Q; COVID-19 Evidence and Recommendations Working Group. Potential effectiveness and safety of antiviral agents in children with coronavirus disease 2019: a rapid review and meta-analysis. Ann Transl Med. 2020 May;8(10):624. doi: 10.21037/atm-20-3301. PMID: 32566561; PMCID: PMC7290634.
  5. Chen B, Zhong H, Ni Y, Liu L, Zhong J, Su X. Epidemiological Trends of Coronavirus Disease 2019 in China. Front Med (Lausanne). 2020 May 29;7:259. doi: 10.3389/fmed.2020.00259. PMID: 32574341; PMCID: PMC7273499.
  6. Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, Zhu H, Zhao W, Han Y, Qin C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses. 2019 Jan 14;11(1):59. doi: 10.3390/v11010059. PMID: 30646565; PMCID: PMC6357155.
  7. Mavian C, Dulcey M, Munoz O, Salemi M, Vittor AY, Capua I. Islands as Hotspots for Emerging Mosquito-Borne Viruses: A One-Health Perspective. Viruses. 2018 Dec 25;11(1):11. doi: 10.3390/v11010011. PMID: 30585228; PMCID: PMC6356932.
  8. Graham BS, Mascola JR, Fauci AS. Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases. JAMA. 2018 Apr 10;319(14):1431-1432. doi: 10.1001/jama.2018.0345. PMID: 29566112.
  9. Yu IT, Li Y, Wong TW, Tam W, Chan AT, Lee JH, Leung DY, Ho T. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med. 2004 Apr 22;350(17):1731-9. doi: 10.1056/NEJMoa032867. PMID: 15102999.
  10. Ahmad A, Eze K, Noulin N, Horvathova V, Murray B, Baillet M, Grey L, Mori J, Adda N. EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge. N Engl J Med. 2022 Feb 17;386(7):655-666. doi: 10.1056/NEJMoa2108903. PMID: 35172056.

Top Experts on “viral infections“